These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17594992)

  • 41. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.
    Anchersen K; Clausen T; Gossop M; Hansteen V; Waal H
    Addiction; 2009 Jun; 104(6):993-9. PubMed ID: 19392907
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services.
    Whitley SD; Kunins HV; Arnsten JH; Gourevitch MN
    J Subst Abuse Treat; 2007 Jul; 33(1):85-90. PubMed ID: 17588493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The methadone program is greatly reduced. Few addicts are referred to Uppsala].
    Orn P
    Lakartidningen; 1996 Dec; 93(49):4502. PubMed ID: 8999223
    [No Abstract]   [Full Text] [Related]  

  • 44. [Opiate users in methadone-assisted rehabilitation one year and two years after admission].
    Ravndal E; Lauritzen G
    Tidsskr Nor Laegeforen; 2004 Feb; 124(3):329-31. PubMed ID: 14963503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Documented effect of methadone, but not naltrexone].
    Heilig M
    Lakartidningen; 2002 Feb; 99(6):551-2. PubMed ID: 11881232
    [No Abstract]   [Full Text] [Related]  

  • 46. Analysis of clinical trials for treatment of opiate dependence: what are the possibilities?
    Jain RB
    NIDA Res Monogr; 1992; 128():116-34; discussion 135-6. PubMed ID: 1436010
    [No Abstract]   [Full Text] [Related]  

  • 47. Prescribing to drug misusers in practice--often effective, but rarely straightforward.
    Seivewright N; Iqbal MZ
    Addict Biol; 2002 Jul; 7(3):269-77. PubMed ID: 12126485
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Using buprenorphine short-term taper to facilitate early treatment engagement.
    Brigham GS; Amass L; Winhusen T; Harrer JM; Pelt A
    J Subst Abuse Treat; 2007 Jun; 32(4):349-56. PubMed ID: 17481458
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methadone treatment.
    Lord FR
    CMAJ; 1999 Nov; 161(10):1241. PubMed ID: 10584082
    [No Abstract]   [Full Text] [Related]  

  • 50. Driving impairment on buprenorphine and slow-release oral morphine in drug-dependent patients.
    Giacomuzzi S; Haaser W; Pilsz L; Riemer Y
    Forensic Sci Int; 2005 Sep; 152(2-3):323-4. PubMed ID: 15921868
    [No Abstract]   [Full Text] [Related]  

  • 51. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
    Winstock AR; Lea T; Sheridan J
    Int J Drug Policy; 2008 Dec; 19(6):450-8. PubMed ID: 18359216
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Divided doses for methadone maintenance.
    Modesto-Lowe V
    Am J Psychiatry; 2008 Oct; 165(10):1358; author reply 1358-9. PubMed ID: 18829892
    [No Abstract]   [Full Text] [Related]  

  • 53. Commentary on Nosyk et al. (2012): detoxification from methadone maintenance therapy: how important is the exact technique that is used?
    Day E
    Addiction; 2012 Sep; 107(9):1630-1. PubMed ID: 22861675
    [No Abstract]   [Full Text] [Related]  

  • 54. Moderate- vs high-dose methadone for opioid dependence.
    Newman RG
    JAMA; 1999 Dec; 282(22):2122; author reply 2122-3. PubMed ID: 10591331
    [No Abstract]   [Full Text] [Related]  

  • 55. [Methadone and buprenorphine--attractive on the street and outside treatment programs].
    Johnson B
    Lakartidningen; 2011 Oct 9-15; 108(45):2309-11. PubMed ID: 22242248
    [No Abstract]   [Full Text] [Related]  

  • 56. [Methadone and thyroid disorders].
    Gundersen R
    Tidsskr Nor Laegeforen; 2001 Nov; 121(29):3445. PubMed ID: 11826797
    [No Abstract]   [Full Text] [Related]  

  • 57. Retrospective analyses of additional services for methadone maintenance patients.
    Abbott PJ; Moore B; Delaney H; Weller S
    J Subst Abuse Treat; 1999; 17(1-2):129-37. PubMed ID: 10435261
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Use of SF-6D utility index in methadone maintenance programs].
    Iraurgi Castillo I
    Med Clin (Barc); 2008 Oct; 131(11):437. PubMed ID: 18928729
    [No Abstract]   [Full Text] [Related]  

  • 59. Take-home "privileges" for methadone maintenance patients: policies versus practices.
    Newman RG
    J Addict Med; 2012 Dec; 6(4):318; author reply 318. PubMed ID: 23131801
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of national guidelines on prescription of methadone: analysis of NHS prescription data, England 1990-2001.
    Strang J; Sheridan J
    BMJ; 2003 Aug; 327(7410):321-2. PubMed ID: 12907486
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.